Harnessing Dietary Phytochemicals to Modulate Signaling Pathways in Cancer Chemoprevention-A Review

Kritika Pandit1, Chandni Garg1, Aashaq H Bhat2

  • 1Department of Botanical and Environmental Sciences, Guru Nanak Dev University, Amritsar, Punjab, India.

PubMed

Insights

Plant-derived phytochemicals show promise for cancer chemoprevention by targeting key cancer mechanisms. These natural compounds offer a safer alternative for developing novel anticancer therapies.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer chemoprevention utilizes agents to inhibit cancer progression.
  • Medicinal plants yield phytochemicals with significant health benefits, especially against cancer.

Purpose of the Study:

  • To review the diverse mechanisms of plant-derived compounds in cancer chemoprevention.
  • To explore the potential of phytochemicals as anticancer therapeutics.

Main Methods:

  • Literature review of studies on phytochemicals and cancer chemoprevention.
  • Analysis of molecular mechanisms including cell cycle arrest, apoptosis, and autophagy.
  • Examination of epigenetic modifications and enzyme expression modulation.

Main Results:

  • Plant compounds induce cell cycle arrest, apoptosis, and autophagy.
  • Phytochemicals reverse epigenetic changes and boost detoxification enzymes.
  • Compounds modulate signaling pathways crucial for tumor growth.

Conclusions:

  • Phytochemicals offer multifaceted chemopreventive effects.
  • Understanding molecular actions is key to optimizing their therapeutic use.
  • Plant-derived compounds are vital for future anticancer drug development.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K